1. Home
  2. CLNN vs FSEA Comparison

CLNN vs FSEA Comparison

Compare CLNN & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLNN
  • FSEA
  • Stock Information
  • Founded
  • CLNN 2012
  • FSEA 1890
  • Country
  • CLNN United States
  • FSEA United States
  • Employees
  • CLNN N/A
  • FSEA N/A
  • Industry
  • CLNN Biotechnology: Pharmaceutical Preparations
  • FSEA Savings Institutions
  • Sector
  • CLNN Health Care
  • FSEA Finance
  • Exchange
  • CLNN Nasdaq
  • FSEA Nasdaq
  • Market Cap
  • CLNN 43.0M
  • FSEA 44.0M
  • IPO Year
  • CLNN N/A
  • FSEA N/A
  • Fundamental
  • Price
  • CLNN $4.00
  • FSEA $9.03
  • Analyst Decision
  • CLNN Strong Buy
  • FSEA
  • Analyst Count
  • CLNN 4
  • FSEA 0
  • Target Price
  • CLNN $59.25
  • FSEA N/A
  • AVG Volume (30 Days)
  • CLNN 56.3K
  • FSEA 6.2K
  • Earning Date
  • CLNN 11-13-2024
  • FSEA 11-08-2024
  • Dividend Yield
  • CLNN N/A
  • FSEA N/A
  • EPS Growth
  • CLNN N/A
  • FSEA N/A
  • EPS
  • CLNN N/A
  • FSEA N/A
  • Revenue
  • CLNN $421,000.00
  • FSEA $11,390,000.00
  • Revenue This Year
  • CLNN N/A
  • FSEA N/A
  • Revenue Next Year
  • CLNN $1,058.37
  • FSEA N/A
  • P/E Ratio
  • CLNN N/A
  • FSEA N/A
  • Revenue Growth
  • CLNN N/A
  • FSEA N/A
  • 52 Week Low
  • CLNN $3.82
  • FSEA $6.40
  • 52 Week High
  • CLNN $12.00
  • FSEA $9.49
  • Technical
  • Relative Strength Index (RSI)
  • CLNN 32.52
  • FSEA 44.83
  • Support Level
  • CLNN $3.88
  • FSEA $9.00
  • Resistance Level
  • CLNN $4.78
  • FSEA $9.20
  • Average True Range (ATR)
  • CLNN 0.50
  • FSEA 0.11
  • MACD
  • CLNN -0.18
  • FSEA -0.01
  • Stochastic Oscillator
  • CLNN 9.48
  • FSEA 13.57

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).

About FSEA First Seacoast Bancorp Inc.

First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.

Share on Social Networks: